Display options
Cite
Hillebrenner M, Zuckerman B, Fiuzat M, et al. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices. JACC Heart Fail. 2016;4(12):974-977doi: 10.1016/j.jchf.2016.09.007.
Hillebrenner, M., Zuckerman, B., Fiuzat, M., Stockbridge, N., & Califf, R. (2016). The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices. JACC. Heart failure, 4(12), 974-977. https://doi.org/10.1016/j.jchf.2016.09.007
Hillebrenner, Matthew, et al. "The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices." JACC. Heart failure vol. 4,12 (2016): 974-977. doi: https://doi.org/10.1016/j.jchf.2016.09.007
Hillebrenner M, Zuckerman B, Fiuzat M, Stockbridge N, Califf R. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices. JACC Heart Fail. 2016 Dec;4(12):974-977. doi: 10.1016/j.jchf.2016.09.007. PMID: 27908396.
Copy Download .nbib Format: NLM
Share it on

JACC Heart Fail. 2016 Dec;4(12):974-977. doi: 10.1016/j.jchf.2016.09.007.

The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.

JACC. Heart failure

Matthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, Norman Stockbridge, Robert Califf

Affiliations

  1. Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: [email protected].
  2. Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland.
  3. Office of the Commissioner, U.S. Food and Drug Administration, Silver, Spring, Maryland.
  4. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver, Spring, Maryland.

PMID: 27908396 DOI: 10.1016/j.jchf.2016.09.007

[No abstract available.]

Keywords: heart failure; regulation

MeSH terms

Publication Types